Electromagnetic navigation bronchoscopy

ENB (Electromagnetic Navigation Bronchoscopy) or EMN bronchoscopy is a medical procedure utilizing electromagnetic technology designed to localize and guide endoscopic tools or catheters through the bronchial pathways of the lung. Using a virtual, three-dimensional (3D) bronchial map from a recently computed tomography (CT) chest scan and disposable catheter set, physicians are able to navigate to a desired location within the lung to biopsy lesions, stage lymph nodes, insert markers to guide radiotherapy or guide brachytherapy catheters.[1]

Components

The ENB system consists of four essential components:

General Overview

Electromagnetic Navigation Bronchoscopy consists of two primary phases: planning and navigation. In the planning phase previously acquired CT scans are utilized to mark and plan pathways to targets within the lung. In the navigation phase these previously planned targets and pathways are displayed and can be utilized for navigation and access deep within the lung. Upon arriving at the target ENB enables multiple applications all within the same procedure.[2]

Planning Phase

CT scans of the patient’s chest are loaded into proprietary software that reconstructs the patient’s airways in multiple 3D images. The physician utilizes these images to mark target locations and plan pathways to these target locations within the lungs.[2]

Navigation Phase

Using the planned pathway created in the Planning Phase and real-time guidance, the physician navigates the steerable sensor probe and extended working channel to the desired target location(s). Once at the desired location, the physician locks the extended working channel in place and the steerable sensor probe is removed. The extended working channel provides access to the target lesion for standard bronchoscopic tools or catheters.[2]

History

According to the Aetna Clinical Policy Bulletin on ENB, “In 2004, the FDA cleared for marketing through the 510(k) process the Medtronic superDimension/Bronchus system, also known as the inReach system (superDimension, Ltd, Israel), a minimally invasive image-guidance localization and navigation system that uses electromagnetic guidance for the management of peripheral lung lesions. The system consists of several components: a guide catheter, a steerable navigation catheter, and planning and navigation software and hardware (i.e., computer and monitor). Navigation is facilitated by an electromagnetic tracking system that detects a position sensor incorporated into a flexible catheter advanced through a bronchoscope. Information obtained during bronchoscopy is super-imposed on previously acquired computed tomography (CT) data and 3-dimensional virtual images. The system was designed to solve the clinical problem of reaching small suspected lesions in the peripheral lung airways and mediastinal lymph nodes and is being proposed as an alternative to open surgical biopsy of distant lung lesions and as an alternative to transthoracic implantation of radiosurgical markers.”[3]

Field Use and Prospective Studies

Despite the medical advances of detection, diagnosis and treatment methods throughout the past 50 years, lung cancer causes more deaths than any other cancer in both men and women.[4] Currently, lung cancer is the most common form of cancer diagnosed in the United States and a major cause of death, accounting for 14% of all cancers.[5]

The most effective way of stopping cancer comes at diagnosis and treatment in the early stages. Lung cancer diagnosed in the early stages yields an 88% survival rate at ten years versus 16% at five years when found in the later stages.[6][7]

Although 1 in 500 chest x-rays show a peripheral lesion,[8] 65% of traditional bronchoscopes fail to reach these distant lesions.[9] More invasive diagnostic techniques are then necessary, posing a greater potential for complications such as pneumothorax.[10] Patients with poor lung function may not tolerate more invasive procedures, leaving them with "watchful waiting" as their only option.

There are four publications that show that peripheral lung lesions can be diagnosed successfully in 69% to 86% of cases using the Medtronic superDimension system.[11][12][13][14]

According to the American Journal of Respiratory and Critical Care Medicine, a prospective…study was conducted to determine the ability of electromagnetic navigation bronchoscopy to sample peripheral lung lesions and mediastinal lymph nodes with standard bronchoscopic instruments and demonstrate safety the ENB.” The results provided a “yield/procedure [rate at] 74% and 100% for peripheral lesions and lymph nodes, respectively.” Additionally, “a diagnosis was obtained in 80.4% of bronchoscopic procedures.” The study concluded that ENB “is a safe method for sampling peripheral and mediastinal lesions with high diagnostic yield independent of lesion size and location”.[15]

A similar study of 40 patients issued in the ERS Journals resulted in an overall 62.5% diagnostic yield and concluded; “electromagnetic navigation bronchoscopy without additional fluoroscopic guidance is a safe and efficient technique for the diagnosis of peripheral pulmonary nodules. The overall diagnostic yield found in the present study is superior to rates reported in most previous studies performed for small peripheral pulmonary nodules with bronchoscopy”.[16]

Virtual bronchoscopy continues to be an active subject for basic engineering research. The Bioelectromagnetics group at University College Cork has developed a novel low-cost tracking system for use in electromagnetic navigation bronchoscopy.[17] The group is also collaborating with the Surgical Planning Laboratory at Harvard Medical School to develop the world's first open-source virtual bronchoscopy module to be implemented in the 3DSlicer environment.[18]

References

  1. 1 2 http://ajrccm.atsjournals.org/cgi/reprint/200603-344OCv1.pdf
  2. 1 2 3 Heinrich D. Becker, M. F. (2005). Bronchoscopic Biopsy of Peripheral Lung Lesions Under Electromagnetic Guidance. Journal of Bronchology, 12-13
  3. ↑ "Electromagnetic Navigation-guided Bronchoscopy". aetna.com.
  4. ↑ Jemal A, et al., CA Cancer J Clin 2007;57;43-66
  5. ↑ American Cancer Society, 2006
  6. ↑ N ENGL J MED 2006;355:1763–1771
  7. ↑ American Cancer Society, Surveillance Research, 2006
  8. ↑ "Homepage - American Lung Association". lungusa.org.
  9. ↑ US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General, 2004.
  10. ↑ Ernst A, et al., Interventional pulmonary procedures. Guidelines from the American College of Chest Physicians. CHEST 2003; 123:1693–1717.
  11. ↑ Becker H, Herth F, Ernst A, Schwarz Y. Journal of Bronchology 2005; 12:9-13
  12. ↑ Gildea T, Mazzone P, Karnak D, Meziane M, Mehta A. Electromagnetic Navigation Diagnostic Bronchoscopy: A Prospective Study. American Journal of Respiratory Critical Care Medicine 2006; 174:982-989.
  13. ↑ Wilson D, Bartlett R. Improved Diagnostic Yield of Bronchoscopy in a Community practice: Combination of Electromagnetic Navigation System and Rapid On-Site Evaluation, Journal of Bronchology, Oct 2007, 14(4):227-232.
  14. ↑ Bernd Lamprecht, B, Porsch, P, Pirich, C, Studnicka, M, Electromagnetic Navigation Bronchoscopy in Combination with PET-CT and Rapid On-site Cytopathologic Examination for Diagnosis of Peripheral Lung Lesions. LUNG 2009, 1877:55-59.
  15. ↑ American Journal of Respiratory and Critical Care Medicine Vol 174. pp. 982–989, (2006)
  16. ↑ D. Makris. "Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions". ersjournals.com.
  17. ↑ "IEEE Xplore - Sign In". doi.org.
  18. ↑ zwonull media GbR. "cars-int.org: CARS 2013". cars-int.org.
This article is issued from Wikipedia - version of the Monday, November 16, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.